DrugDashboards

Market view

carbachol and brimonidine tartrate

2 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for carbachol and brimonidine tartrate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • YuvezziSep 2, 2026
    Mfr exited
    Visus Therapeutics, Inc. · carbachol and brimonidine tartrate
  • YuvezziAug 26, 2026
    Mfr entered
    Visus Therapeutics, Inc. · carbachol and brimonidine tartrate
  • YuvezziJul 29, 2026
    Mfr exited
    Visus Therapeutics, Inc. · carbachol and brimonidine tartrate
  • YuvezziJul 22, 2026
    Mfr entered
    Visus Therapeutics, Inc. · carbachol and brimonidine tartrate

Same drug class

Other molecules FDA puts in alpha-Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Carbachol and brimonidine tartrate in shortage right now?
No. FDA does not currently list Carbachol and brimonidine tartrate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Carbachol and brimonidine tartrate?
1 company has marketed Carbachol and brimonidine tartrate in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.